04 Dec 2006 - Talecris Biotherapeutics Inc. announced the establishment of Talecris Biotherapeutics GmbH, its European headquarters in Frankfurt, Germany. Europe represents the second expansion in 2006 for the North Carolina-based biotherapeutics manufacturer, completing the next regional phase in the company's ongoing global expansion plan.
"Our expansion into Europe signifies another key milestone demonstrating the strategic growth we have planned for our company," said Alberto Martinez, M.D., CEO and President, Talecris Biotherapeutics. "We established Talecris Europe to deliver tailored sales and support services to our European customers, and our European leadership team brings the knowledge, experience and dedication to do exactly that."
 |
www.bionity.com/news/e/59847 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/59847 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |